NCT01086397

Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia

Distribution Of PCV13 Serotype Streptococcus Pneumoniae In Adults 50 Years And Older Presenting To Select US Hospitals With Radiographically-Confirmed Community-Acquired Pneumonia (CAP)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 782 (actual)
• Sponsor: Pfizer · Industry
• Sex: All
• Age: 50 Years
• Healthy volunteers: Not accepted

Summary

The main purpose of this study is to use an investigational urine assay to estimate the proportion of pneumonia in adults 50 years or older in different areas throughout the US that is caused by certain types of the bacteria Streptococcus pneumoniae (also called pneumococcus).

Conditions

• Pneumonia, Pneumococcal
• Vaccines, Pneumococcal

Interventions

Type	Name	Description
PROCEDURE	Urine sample collection	All subjects have non-invasive urine sample collection performed

Timeline

• Start date: 2010-02-01
• Primary completion: 2011-09-01
• Completion: 2011-10-01
• First posted: 2010-03-15
• Last updated: 2012-03-15

Locations

14 sites across 1 country: United States